GlobalRPh RX List - FLAGYL
- Product / population
- Oral metronidazole; selected renal-population guidance, not a dialysis schedule.
- Renal measure
- Mild/moderate impairment versus severe impairment or ESRD.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
No renal dose adjustment is stated for mild-to-moderate impairment. Metabolites may accumulate with severe impairment or ESRD in patients not receiving hemodialysis; monitor for metronidazole-related adverse effects. Dialysis timing and supplemental-dose decisions require the separate complete source sections and are not inferred from this paragraph.